Berral-González, A.; Arroyo, M.M.; Alonso-López, D.; Rivas-López, M.J.; Sánchez-Santos, J.M.; De Las Rivas, J.
Pharmacogenomic Drug–Target Network Analysis Reveals Similarity Profiles Among FDA–Approved Cancer Drugs. Pharmaceutics 2025, 17, 1421.
https://doi.org/10.3390/pharmaceutics17111421
AMA Style
Berral-González A, Arroyo MM, Alonso-López D, Rivas-López MJ, Sánchez-Santos JM, De Las Rivas J.
Pharmacogenomic Drug–Target Network Analysis Reveals Similarity Profiles Among FDA–Approved Cancer Drugs. Pharmaceutics. 2025; 17(11):1421.
https://doi.org/10.3390/pharmaceutics17111421
Chicago/Turabian Style
Berral-González, Alberto, Monica M. Arroyo, Diego Alonso-López, MarÃa Jesús Rivas-López, José Manuel Sánchez-Santos, and Javier De Las Rivas.
2025. "Pharmacogenomic Drug–Target Network Analysis Reveals Similarity Profiles Among FDA–Approved Cancer Drugs" Pharmaceutics 17, no. 11: 1421.
https://doi.org/10.3390/pharmaceutics17111421
APA Style
Berral-González, A., Arroyo, M. M., Alonso-López, D., Rivas-López, M. J., Sánchez-Santos, J. M., & De Las Rivas, J.
(2025). Pharmacogenomic Drug–Target Network Analysis Reveals Similarity Profiles Among FDA–Approved Cancer Drugs. Pharmaceutics, 17(11), 1421.
https://doi.org/10.3390/pharmaceutics17111421